©The Author(s) 2026.
World J Gastroenterol. Feb 7, 2026; 32(5): 113505
Published online Feb 7, 2026. doi: 10.3748/wjg.v32.i5.113505
Published online Feb 7, 2026. doi: 10.3748/wjg.v32.i5.113505
Figure 2 Receiver operating characteristic curves for mucosal healing, C-reactive protein normalization, combined endpoint and antidrug antibody status.
A: Mucosal healing; B: C-reactive protein; C: Composite endpoint; D: Antidrug antibody.
- Citation: Mould DR, Kutschera M, Primas C, Reinisch S, Novacek G, Lichtenberger C, Dervieux T, Bae Y, Lee SH, Lee JH, Reinisch W. Identification of strong correlations of clearance with clinical outcomes for inflammatory bowel disease. World J Gastroenterol 2026; 32(5): 113505
- URL: https://www.wjgnet.com/1007-9327/full/v32/i5/113505.htm
- DOI: https://dx.doi.org/10.3748/wjg.v32.i5.113505